Novartis, Gilead in joint financing of personalized medicine platform 06-Feb-2020 By Vassia Barba Vineti’s latest financing round sees Novartis and Gilead join forces to invest in technology platform that enables scale-up of CAR Ts and allogeneic cell therapies.